Phase 2 trial
Term · Environment · MLC-T-ENV-030773
Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects.
| Identifier | MLC-T-ENV-030773 |
|---|---|
| Field | Environment |
| Subject | Research |
| References | after FDA CDER handbook, ICH E8; CDISC-GLOSS |
Record as JSON
{
"id": "MLC-T-ENV-030773",
"term": "Phase 2 trial",
"field": "Environment",
"term_source": "Phase 2 Trial",
"definition": "Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects.",
"subject": "Research",
"references": [
"after FDA CDER handbook, ICH E8; CDISC-GLOSS"
],
"url": "https://mlchart.com/terminology/environment/phase-2-trial/"
}
Record 20,289 of 29,894 in Environment terminology (MLC-0121). Request the full dataset.